Long term biochemical recurrence free survival after radical prostatectomy for cancer: Comparative analysis according to surgical approach and clinicopathological stage

被引:1
|
作者
Rizk, J. [1 ]
Ouzzane, A. [1 ]
Flamand, V. [1 ]
Fantoni, J. -C. [1 ]
Puech, P. [2 ]
Leroy, X. [3 ]
Villers, A. [1 ]
机构
[1] Univ Lille Nord De France, CHRU Lille, Serv Urol, F-59000 Lille, France
[2] Univ Lille Nord De France, CHRU Lille, Serv Radiol, F-59000 Lille, France
[3] Univ Lille Nord De France, CHRU Lille, Inst Pathol, F-59000 Lille, France
来源
PROGRES EN UROLOGIE | 2015年 / 25卷 / 03期
关键词
Prostatectomy; Outcome assessment; Prostatic neoplasms; Recurrence; Disease-free survival; CLASSIFICATION; VALIDATION; PREDICTORS; OUTCOMES; MARGINS;
D O I
10.1016/j.purol.2014.12.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. - To assess long term biochemical recurrence free survival after radical prostatectomy according to open, laparoscopic and robot-assisted surgical approach and clinicopathological stage. Material and methods.- A cohort study of 1313 consecutive patients treated by radical prostatectomy for localized or locally advanced prostate cancer between 2000 and 2013. Open surgery (63.7%), laparoscopy (10%) and robot-assisted laparoscopy (26.4%) were performed. Biochemical recurrence was defined by PSA > 0,1 ng/mL. The biochemical recurrence free survival was described by Kaplan Meier method and prognostic factors were analysed by multivariable Cox regression. Results. - Median follow-up was 57 months (IQR: 31-90). Ten years biochemical recurrence free survival was 88.5%, 71.6% and 53.5% respectively for low, intermediate and high-risk D'Amico groups. On multivariable analysis, the worse prognostic factor was Gleason score (P < 0.001). Positive surgical margins rate was 53% in pT3 tumours and 24% in pT2 tumours (P < 0.001). Biochemical recurrence free survival (P = 0.06) and positive surgical margins rate (P = 0.87) were not statistically different between the three surgical approaches. Conclusion. - Biochemical recurrence free survival in our study does not differ according to surgical approach and is similar to published series. Ten years biochemical recurrence free survival for high-risk tumours without hormone therapy is 54% justifying the role of surgery in the therapeutic conversations in this group of tumours. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 50 条
  • [21] Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence
    Pompe, Raisa S.
    Gild, Philipp
    Karakiewicz, Pierre I.
    Bock, Lea-Philine
    Schlomm, Thorsten
    Steuber, Thomas
    Graefen, Markus
    Huland, Hartwig
    Tian, Zhe
    Tilki, Derya
    PROSTATE, 2018, 78 (09): : 676 - 681
  • [22] The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy
    Ward, JF
    Blute, ML
    Slezak, J
    Bergstralh, EJ
    Zincke, H
    JOURNAL OF UROLOGY, 2003, 170 (05): : 1872 - 1876
  • [23] Predictors of long-term biochemical-free survival following salvage radical prostatectomy
    Sanderson, KM
    Lieskovsky, G
    Stein, JP
    Cai, J
    Skinner, DG
    Penson, DF
    JOURNAL OF UROLOGY, 2005, 173 (04): : 221 - 221
  • [24] Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer
    Chun, Felix K. -H.
    Graefen, Markus
    Zacharias, Mario
    Haese, Alexander
    Steuber, Thomas
    Schlomm, Thorsten
    Karakiewicz, Pierre I.
    Huland, Hartwig
    WORLD JOURNAL OF UROLOGY, 2006, 24 (03) : 273 - 280
  • [25] Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer
    Felix K.-H. Chun
    Markus Graefen
    Mario Zacharias
    Alexander Haese
    Thomas Steuber
    Thorsten Schlomm
    Jochen Walz
    Pierre I. Karakiewicz
    Hartwig Huland
    World Journal of Urology, 2006, 24 : 273 - 280
  • [26] Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy
    O'Malley, KJ
    Pound, CR
    Walsh, PC
    Epstein, JI
    Partin, AW
    JOURNAL OF UROLOGY, 2002, 168 (01): : 377 - 377
  • [27] Is There a Bioenergetic Signature of Prostate Cancer According to Gleason Grading and Time of Biochemical Recurrence After Radical Prostatectomy?
    Billis, Athanase
    Favaro, Wagner
    da Silva, Rogerio C.
    Foratto, Alexandre
    Freitas, Leandro
    Costa, Larissa B.
    Barreto, Icleia S.
    MODERN PATHOLOGY, 2018, 31 : 329 - 329
  • [28] Is There a Bioenergetic Signature of Prostate Cancer According to Gleason Grading and Time of Biochemical Recurrence After Radical Prostatectomy?
    Billis, Athanase
    Favaro, Wagner
    da Silva, Rogerio C.
    Foratto, Alexandre
    Freitas, Leandro
    Costa, Larissa B.
    Barreto, Icleia S.
    LABORATORY INVESTIGATION, 2018, 98 : 329 - 329
  • [29] Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy
    S Narita
    K Mitsuzuka
    T Yoneyama
    N Tsuchiya
    T Koie
    N Kakoi
    S Kawamura
    Y Kaiho
    C Ohyama
    T Tochigi
    T Yamaguchi
    T Habuchi
    Y Arai
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 271 - 276
  • [30] Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy
    Narita, S.
    Mitsuzuka, K.
    Yoneyama, T.
    Tsuchiya, N.
    Koie, T.
    Kakoi, N.
    Kawamura, S.
    Kaiho, Y.
    Ohyama, C.
    Tochigi, T.
    Yamaguchi, T.
    Habuchi, T.
    Arai, Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (03) : 271 - 276